332 related articles for article (PubMed ID: 21042276)
1. Emerging roles for the non-canonical IKKs in cancer.
Shen RR; Hahn WC
Oncogene; 2011 Feb; 30(6):631-41. PubMed ID: 21042276
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer.
Kim JY; Beg AA; Haura EB
Expert Opin Ther Targets; 2013 Oct; 17(10):1109-12. PubMed ID: 23984985
[TBL] [Abstract][Full Text] [Related]
3. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?
Chau TL; Gioia R; Gatot JS; Patrascu F; Carpentier I; Chapelle JP; O'Neill L; Beyaert R; Piette J; Chariot A
Trends Biochem Sci; 2008 Apr; 33(4):171-80. PubMed ID: 18353649
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
5. The IKK-related kinases: from innate immunity to oncogenesis.
Clément JF; Meloche S; Servant MJ
Cell Res; 2008 Sep; 18(9):889-99. PubMed ID: 19160540
[TBL] [Abstract][Full Text] [Related]
6. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
7. The non-canonical IκB kinases IKKε and TBK1 as potential targets for the development of novel therapeutic drugs.
Niederberger E; Möser CV; Kynast KL; Geisslinger G
Curr Mol Med; 2013 Aug; 13(7):1089-97. PubMed ID: 23157677
[TBL] [Abstract][Full Text] [Related]
8. Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.
Zhang H; Chen L; Cai SH; Cheng H
Leuk Res; 2016 Jul; 46():37-44. PubMed ID: 27123832
[TBL] [Abstract][Full Text] [Related]
9. IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.
Verhelst K; Verstrepen L; Carpentier I; Beyaert R
Biochem Pharmacol; 2013 Apr; 85(7):873-80. PubMed ID: 23333767
[TBL] [Abstract][Full Text] [Related]
10. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
11. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism.
Batra RK; Lin Y; Sharma S; Dohadwala M; Luo J; Pold M; Dubinett SM
Cancer Res; 2003 Feb; 63(3):642-6. PubMed ID: 12566308
[TBL] [Abstract][Full Text] [Related]
13. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
14. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis.
Guo Y; Li R; Tan Z; Shi J; Fu Y; Song Y; Zhu M; Zhang L; Huang J
Mol Immunol; 2020 May; 121():195-203. PubMed ID: 32298923
[TBL] [Abstract][Full Text] [Related]
15. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.
Romashkova JA; Makarov SS
Nature; 1999 Sep; 401(6748):86-90. PubMed ID: 10485711
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
18. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.
Möser CV; Stephan H; Altenrath K; Kynast KL; Russe OQ; Olbrich K; Geisslinger G; Niederberger E
J Neuroinflammation; 2015 May; 12():100. PubMed ID: 25997745
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
20. IκB kinases increase Myc protein stability and enhance progression of breast cancer cells.
Yeh PY; Lu YS; Ou DL; Cheng AL
Mol Cancer; 2011 May; 10():53. PubMed ID: 21575199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
